Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1264-1269
Published online before print May 12, 2005, doi: 10.1161/01.STR.0000166180.91042.02
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/1264    most recent
01.STR.0000166180.91042.02v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Chan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Chan, P. H.
Related Collections
Right arrow Apoptosis
Right arrow Genetically altered mice

(Stroke. 2005;36:1264.)
© 2005 American Heart Association, Inc.


Original Contributions

Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and Erythropoietin

Jing Liu, MD, PhD; Purnima Narasimhan, PhD; Fengshan Yu, MD Pak H. Chan, PhD

From the Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, Stanford, California.

Correspondence to Pak H. Chan, PhD, Neurosurgical Laboratories, Stanford University, 1201 Welch Rd, MSLS #P314 Stanford, CA 94305-5487. E-mail phchan{at}stanford.edu

Background and Purpose— Hypoxic preconditioning is an endogenous protection against subsequent lethal hypoxia, but the mechanism involved is not understood. Hypoxia is followed by reactive oxygen species (ROS) production and induces hypoxia-inducible factor (HIF) and its downstream factor erythropoietin (Epo), which is associated with neuroprotection. We hypothesized that these endogenous processes may contribute to hypoxic preconditioning.

Methods— We used a mouse neuronal culture model, with 2 hours of hypoxia as preconditioning followed by 15 hours of hypoxic insult, and examined the expression of HIF-1{alpha}, Epo, and their downstream proteins by Western blotting. Copper/zinc–superoxide dismutase (SOD1) transgenic (Tg) mice were used to detect the effect of ROS. Cell survival and apoptosis were detected by mitogen-activated protein 2 quantification, apoptotic-related DNA fragmentation, and caspase-3 fragmentation. Antisense Epo was used to block endogenously produced Epo.

Results— Hypoxic preconditioning was protective in wild-type (Wt) neurons but not in neurons obtained from SOD1 Tg mice. In Wt neurons, HIF-1{alpha} and Epo expression showed a greater increase after hypoxia compared with Tg neurons and reached a higher level with preconditioned hypoxia, followed by pJak2, pStat5, and nuclear factor {kappa}B (NF-{kappa}B) expression. Antisense Epo decreased these downstream proteins and the neuroprotection of hypoxic preconditioning.

Conclusions— Hypoxic preconditioning induces ROS, which may downregulate the threshold for production of HIF-1{alpha} and Epo expression during subsequent lethal hypoxia, thus exerting neuroprotection through the Jak2–Stat5 and NF-{kappa}B pathways.


Key Words: superoxide dismutase




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. El Hasnaoui-Saadani, A. Pichon, D. Marchant, P. Olivier, T. Launay, P. Quidu, M. Beaudry, A. Duvallet, J.-P. Richalet, and F. Favret
Cerebral adaptations to chronic anemia in a model of erythropoietin-deficient mice exposed to hypoxia
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R801 - R811.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
X. Hu, S. P. Yu, J. L. Fraser, Z. Lu, M. E. Ogle, J.-A. Wang, and L. Wei
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 799 - 808.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Nangaku, Y. Izuhara, S. Takizawa, T. Yamashita, Y. Fujii-Kuriyama, O. Ohneda, M. Yamamoto, C. van Ypersele de Strihou, N. Hirayama, and T. Miyata
A Novel Class of Prolyl Hydroxylase Inhibitors Induces Angiogenesis and Exerts Organ Protection Against Ischemia
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2548 - 2554.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kunz, L. Park, T. Abe, E. F. Gallo, J. Anrather, P. Zhou, and C. Iadecola
Neurovascular Protection by Ischemic Tolerance: Role of Nitric Oxide and Reactive Oxygen Species
J. Neurosci., July 4, 2007; 27(27): 7083 - 7093.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Q. Cheng, T. Nguyen, H. Song, and J. Bonanno
Hypoxia Protects Human Corneal Endothelium from Tertiary Butyl Hydroperoxide and Paraquat-Induced Cell Death In Vitro
Experimental Biology and Medicine, March 1, 2007; 232(3): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. Yin, A. P. Signore, M. Iwai, G. Cao, Y. Gao, M. J. Johnnides, R. W. Hickey, and J. Chen
Preconditioning Suppresses Inflammation in Neonatal Hypoxic Ischemia Via Akt Activation
Stroke, March 1, 2007; 38(3): 1017 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. C. Chavez, O. Baranova, J. Lin, and P. Pichiule
The Transcriptional Activator Hypoxia Inducible Factor 2 (HIF-2/EPAS-1) Regulates the Oxygen-Dependent Expression of Erythropoietin in Cortical Astrocytes
J. Neurosci., September 13, 2006; 26(37): 9471 - 9481.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Liu, P. Narasimhan, Y.-S. Lee, Y. Seon Song, H. Endo, F. Yu, and P. H. Chan
Mild hypoxia promotes survival and proliferation of SOD2-deficient astrocytes via c-Myc activation.
J. Neurosci., April 19, 2006; 26(16): 4329 - 4337.
[Abstract] [Full Text] [PDF]